Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2010 1
2011 1
2015 2
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Le règlement européen « essais cliniques » : articulation avec la loi Jardé : un atelier de Giens.
Lemaire F, Marchenay B, Chassany O, Barthélémy P; les participants à la table ronde N°2 de Giens XXX :; Bouzzagou M, Comet D, Delval C, Dubray C, Fouret C, Frija-Orvoen E, Gambotti L, Lamarque V, d'Orsay G, Plattner V, Sibenaler C, Roux J, Thoby F. Lemaire F, et al. Among authors: frija orvoen e. Therapie. 2015 Jan-Feb;70(1):21-8. doi: 10.2515/therapie/2014229. Therapie. 2015. PMID: 27393394 French. No abstract available.
Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms.
Vernet C, Redolfi S, Attali V, Konofal E, Brion A, Frija-Orvoen E, Pottier M, Similowski T, Arnulf I. Vernet C, et al. Among authors: frija orvoen e. Eur Respir J. 2011 Jul;38(1):98-105. doi: 10.1183/09031936.00040410. Epub 2011 Mar 15. Eur Respir J. 2011. PMID: 21406511 Free article.
The European "clinical trial" regulation; relationship with the Jardé Act: a Giens workshop.
Lemaire F, Marchenay B, Chassany O; participants of round table N°2 of Giens XXX:; Barthélémy P, Bouzzagou M, Comet D, Delval C, Dubray C, Fouret C, Frija-Orvoen E, Gambotti L, Lamarque V, d'Orsay G, Plattner V, Sibenaler C, Roux J, Thoby F. Lemaire F, et al. Among authors: frija orvoen e. Therapie. 2015 Jan-Feb;70(1):21-36. doi: 10.2515/therapie/2014234. Epub 2015 Feb 16. Therapie. 2015. PMID: 25679191 English, French.
Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosis.
Sanjak M, Salachas F, Frija-Orvoen E, Theys P, Hutchinson D, Verheijde J, Pianta T, Stewart H, Brooks BR, Meininger V, Douillet P; Xaliproden [SR57746A] ALS International Study Group. Sanjak M, et al. Among authors: frija orvoen e. Amyotroph Lateral Scler. 2010 Aug;11(4):383-8. doi: 10.3109/17482960903486083. Amyotroph Lateral Scler. 2010. PMID: 20192884